These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 16288483)

  • 1. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.
    Littlewood JM; Wolfe SP; Conway SP
    Pediatr Pulmonol; 2006 Jan; 41(1):35-49. PubMed ID: 16288483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of malabsorption in cystic fibrosis.
    Littlewood JM; Wolfe SP
    Paediatr Drugs; 2000; 2(3):205-22. PubMed ID: 10937471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
    N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic exocrine insufficiency: diagnostic evaluation and replacement therapy with pancreatic enzymes.
    Hammer HF
    Dig Dis; 2010; 28(2):339-43. PubMed ID: 20814209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of maldigestion associated with pancreatic insufficiency.
    Perry RS; Gallagher J
    Clin Pharm; 1985; 4(2):161-9. PubMed ID: 3987214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
    Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of pancreatic insufficiency].
    Ansaldi N; Santini B; Garbagni C
    Pediatr Med Chir; 1983; 5(4):149-55. PubMed ID: 6557569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Konstan MW; Stern RC; Trout JR; Sherman JM; Eigen H; Wagener JS; Duggan C; Wohl ME; Colin P
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1365-71. PubMed ID: 15606399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis.
    Laiho KM; Gavin J; Murphy JL; Connett GJ; Wootton SA
    Clin Nutr; 2004 Jun; 23(3):347-53. PubMed ID: 15158298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment.
    Bruno MJ; Haverkort EB; Tytgat GN; van Leeuwen DJ
    Am J Gastroenterol; 1995 Sep; 90(9):1383-93. PubMed ID: 7661155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice.
    Wouthuyzen-Bakker M; Bodewes FA; Verkade HJ
    J Cyst Fibros; 2011 May; 10(3):150-8. PubMed ID: 21459688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrition in cystic fibrosis.
    Matel JL; Milla CE
    Semin Respir Crit Care Med; 2009 Oct; 30(5):579-86. PubMed ID: 19760545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis.
    Borowitz D; Stevens C; Brettman LR; Campion M; Wilschanski M; Thompson H;
    J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):248-57. PubMed ID: 22266487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
    Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients.
    Borowitz D; Goss CH; Stevens C; Hayes D; Newman L; O'Rourke A; Konstan MW; Wagener J; Moss R; Hendeles L; Orenstein D; Ahrens R; Oermann CM; Aitken ML; Mahl TC; Young KR; Dunitz J; Murray FT
    Pancreas; 2006 Apr; 32(3):258-63. PubMed ID: 16628080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Croatian guidelines for the management of pancreatic exocrine insufficiency].
    Rustemović N; Krznarić Z; Bender DV; Ostojić R; Cavka SC; Milić S; Anić B; Ljubicić N; Mesarić J; Stimac D; ; ; ; ;
    Lijec Vjesn; 2012; 134(5-6):141-7. PubMed ID: 22930931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.